Skip to main content
Fig. 5 | BMC Medical Genomics

Fig. 5

From: SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancer

Fig. 5

SYNJ2 expression in pan-cancer and its prediction ability for multiple cancers. A SYNJ2 expression in various cancer cell lines. B Differential expression of SYNJ2 between normal cancer tissues; nsp > 0.05; *p < 0.05; **p < 0.01; ***p < 0.001; p-value is based on the Wilcoxon rank-sum test. C The prediction ability of SYNJ2 expression for multiple cancers. D The prediction ability of SYNJ2 expression for pan-cancers

Back to article page